NMPA Approval

Osimertinib Mesylate Tablets

Approval Number

国药准字HJ20170166

Registration Date

August 30, 2021

Previous Approval Numbers

H20170166

Drug Information

Generic Name

甲磺酸奥希替尼片

Trade Name

泰瑞沙

Dosage Form

片剂

Strength

40mg(按C₂₈H₃₃N₇O₂计)

Drug Type

化学药品

Registration Date

August 30, 2021

Expiry Date

August 29, 2026

Company Address

SE-151 85 Sodertalje, Sweden

Company Address

Gartunavagen, SE-152 57 Sodertalje, Sweden

Empowering clinical research with data-driven insights and AI-powered tools.

甲磺酸奥希替尼片 - NMPA 批准文号 | MedPath